ATE116982T1 - 1-indolylalkyl-4-(substituierte pyridinyl)- piperazine. - Google Patents

1-indolylalkyl-4-(substituierte pyridinyl)- piperazine.

Info

Publication number
ATE116982T1
ATE116982T1 AT89110485T AT89110485T ATE116982T1 AT E116982 T1 ATE116982 T1 AT E116982T1 AT 89110485 T AT89110485 T AT 89110485T AT 89110485 T AT89110485 T AT 89110485T AT E116982 T1 ATE116982 T1 AT E116982T1
Authority
AT
Austria
Prior art keywords
hydrogen
independently selected
indolylalkyl
piperazine
substituted pyridinyl
Prior art date
Application number
AT89110485T
Other languages
English (en)
Inventor
David William Smith
Frank D Yocca
Joseph Paul Yevich
Ronald John Mattson
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE116982T1 publication Critical patent/ATE116982T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01MPROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M6/00Primary cells; Manufacture thereof
    • H01M6/04Cells with aqueous electrolyte
    • H01M6/06Dry cells, i.e. cells wherein the electrolyte is rendered non-fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01MPROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M4/00Electrodes
    • H01M4/02Electrodes composed of, or comprising, active material
    • H01M4/62Selection of inactive substances as ingredients for active masses, e.g. binders, fillers
    • H01M4/621Binders

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Manufacturing & Machinery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT89110485T 1988-06-10 1989-06-09 1-indolylalkyl-4-(substituierte pyridinyl)- piperazine. ATE116982T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20484588A 1988-06-10 1988-06-10
US07/338,253 US4954502A (en) 1988-06-10 1989-04-14 1-indolyalkyl-4-(substituted-pyridinyl)piperazines

Publications (1)

Publication Number Publication Date
ATE116982T1 true ATE116982T1 (de) 1995-01-15

Family

ID=26899839

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89110485T ATE116982T1 (de) 1988-06-10 1989-06-09 1-indolylalkyl-4-(substituierte pyridinyl)- piperazine.

Country Status (17)

Country Link
US (1) US4954502A (de)
EP (1) EP0345808B1 (de)
JP (1) JP2786480B2 (de)
KR (1) KR0128210B1 (de)
AT (1) ATE116982T1 (de)
AU (1) AU624147B2 (de)
CA (1) CA1337421C (de)
CY (1) CY1846A (de)
DE (1) DE68920482T2 (de)
DK (1) DK283589A (de)
ES (1) ES2067500T3 (de)
FI (1) FI95698C (de)
HK (1) HK83295A (de)
IE (1) IE66569B1 (de)
NO (1) NO174296C (de)
PT (1) PT90805B (de)
SG (1) SG32583G (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120843A (en) * 1987-04-27 1992-06-09 Upjohn Pharmaceutically active amines
US4975445A (en) * 1989-12-06 1990-12-04 Warner-Lambert Company Substituted cyclohexenes as central nervous system agents
US5563142A (en) * 1989-12-28 1996-10-08 The Upjohn Company Diaromatic substituted compounds as anti-HIV-1 agents
CA2071529C (en) * 1989-12-28 2001-03-20 Donna Lee Romero Diaromatic substituted anti-aids compounds
US5077293A (en) * 1990-06-29 1991-12-31 Bristol-Myers Squibb Co. 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines
CA2043709C (en) * 1990-06-29 2002-01-22 David W. Smith Antimigraine alkoxypyrimidine derivatives
US5270312A (en) * 1990-11-05 1993-12-14 Warner-Lambert Company Substituted piperazines as central nervous system agents
US5124332A (en) * 1991-01-28 1992-06-23 Warner-Lambert Company Substituted indoles as central nervous system agents
US5177088A (en) * 1991-04-17 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 3-(pyridinylamino)-indoles
US5328920A (en) * 1991-04-17 1994-07-12 Hoechst-Roussel Pharmaceuticals Incorporated Substituted (pyridinylamino)-indoles
US5599930A (en) * 1991-07-03 1997-02-04 The Upjohn Company Substituted indoles as anti-AIDS pharmaceuticals
US5145973A (en) * 1991-09-30 1992-09-08 Union Carbide Chemicals & Plastics Technology Corporation Oxa-Bicyclic polyfunctional compounds and preparation thereof
US5206393A (en) * 1991-09-30 1993-04-27 Union Carbide Chemicals & Plastics Technology Corporation Oxa-bicyclic polyfunctional compounds and preparation thereof
US5314896A (en) * 1991-11-20 1994-05-24 Warner-Lambert Company 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
CA2084531A1 (en) * 1991-12-19 1993-06-20 David W. Smith Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines
CA2091204C (en) * 1992-03-11 1997-04-08 Ronald J. Mattson Antiischemic-piperazinyl and piperidinyl-cyclohexanes
CA2152160A1 (en) * 1992-12-21 1994-07-07 Tomoyuki Ikemoto N-substituted indole derivative
CA2130078A1 (en) * 1993-09-16 1995-03-17 Jonas A. Gylys Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
US5391570A (en) * 1993-10-14 1995-02-21 Bristol-Myers Squibb Aminomethyl-benzodioxane and benzopyran serotonergic agents
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
US5468767A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antidepressant 3-(aminocycloalkenyl)-indole-5-nitrile derivatives
GB9423682D0 (en) * 1994-11-23 1995-01-11 Merck Sharp & Dohme Therapeutic agents
US5618816A (en) * 1995-03-02 1997-04-08 Bristol-Myers Squibb Company Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines
JPH09124643A (ja) * 1995-08-14 1997-05-13 Bristol Myers Squibb Co 抗うつ作用を有する1−アリールアルキル−4−(アルコキシピリジニル)−又は4−(アルコキシピリミジニル)ピペラジン誘導体
AT403803B (de) 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
JP3185222B2 (ja) * 1997-01-21 2001-07-09 ウェルファイド株式会社 チオフェン化合物およびその医薬用途
US6150533A (en) * 1998-04-08 2000-11-21 American Home Products Corp. N-aryloxyethyl-indoly-alkylamines for the treatment of depression
DE69903930T2 (de) * 1998-04-08 2003-07-17 Wyeth, Madison N-aryloxyethyl-indolyl-alkylamine zur behandlung von depressionen
TW520367B (en) * 1998-04-29 2003-02-11 Wyeth Corp Indolyl derivatives as serotonergic agents
FR2786769B1 (fr) * 1998-12-04 2002-10-25 Synthelabo Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
US6313126B1 (en) * 1999-01-07 2001-11-06 American Home Products Corp Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
DE60011570T2 (de) * 1999-01-07 2004-11-25 Wyeth Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
TR200101939T2 (tr) 1999-01-28 2002-05-21 Bristol-Myers Squibb Company Antidepresan heterosiklik bileşikler
US7265115B2 (en) 1999-01-29 2007-09-04 Abbott Laboratories Diazabicyclic CNS active agents
JP2003513969A (ja) * 1999-11-08 2003-04-15 ワイス 5−htトランスポーターとしてのn−アリル−(ホモピペラジニル)−シクロヘキシルアミン
PL202463B1 (pl) 2000-03-31 2009-06-30 Sanochemia Pharmazeutika Ag Pochodne galantaminy, sposób ich wytwarzania, środek leczniczy zawierajacy te pochodne, zastosowanie pochodnej galantaminy do wytwarzania środków leczniczych, sposób wytwarzania środków leczniczych oraz sposób oddzielania (+)- i (-)-izomerów
US6809105B2 (en) 2000-04-27 2004-10-26 Abbott Laboratories Diazabicyclic central nervous system active agents
US6552015B2 (en) 2000-08-03 2003-04-22 Pfizer Inc. Azabicycloalkane derivatives and therapeutic uses thereof
NZ525700A (en) * 2000-11-20 2004-12-24 Biovitrum Ab Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5HT-2 receptor
SE0004245D0 (sv) 2000-11-20 2000-11-20 Pharmacia Ab Novel compounds and their use
AU2004221812B2 (en) * 2003-03-19 2010-02-18 Exelixis Inc. Tie-2 modulators and methods of use
US20090238761A1 (en) * 2005-01-03 2009-09-24 Universita Degli Studi Di Siena Novel Aryl Piperazine Derivatives With Medical Utility
ES2302671T1 (es) * 2006-08-29 2008-08-01 Teva Pharmaceutical Industries Ltd. Procedimientos para la sintesis de 5-fenil-1-tritil-1h-tetrazol.
MX2010009920A (es) * 2008-03-14 2010-09-30 Merck Patent Gmbh Compuestos de azaindol para tratamiento de trastornos del sistema nervioso central.
CN104163813B (zh) * 2013-05-16 2017-02-01 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
EP3027607B1 (de) 2013-07-29 2020-08-26 Sunshine Lake Pharma Co., Ltd. Substituierte heteroarylverbindungen und verfahren zur verwendung davon
CN104725363B (zh) * 2013-12-20 2019-03-01 广东东阳光药业有限公司 取代的哌嗪化合物及其使用方法和用途
WO2015090235A1 (en) * 2013-12-20 2015-06-25 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use thereof
WO2016192657A1 (en) 2015-06-03 2016-12-08 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof
WO2017025058A1 (zh) * 2015-08-13 2017-02-16 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
JP7282082B2 (ja) 2017-09-29 2023-05-26 サンシャイン・レイク・ファーマ・カンパニー・リミテッド 置換ピリミジンピペラジン化合物及びその使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB944443A (de) * 1959-09-25 1900-01-01
US3468882A (en) 1966-10-07 1969-09-23 Sterling Drug Inc Phenylhydrazone derivatives as intermediates for preparing indoles
GB1189064A (en) * 1967-05-01 1970-04-22 Sterling Drug Inc Indole Derivatives
US3472855A (en) * 1967-05-29 1969-10-14 Sterling Drug Inc 1-((benz(g)-indolyl)-lower-alkyl)-4-substituted-piperazines
US4302589A (en) * 1980-05-08 1981-11-24 American Cyanamid Company Cis-mono and disubstituted-2-methyl-3-[(piperazinyl) and (piperidino)ethyl]indolines, intermediates for their preparation and methods of preparation

Also Published As

Publication number Publication date
IE891861L (en) 1989-12-10
US4954502A (en) 1990-09-04
JP2786480B2 (ja) 1998-08-13
FI892787L (fi) 1989-12-11
DE68920482D1 (de) 1995-02-23
EP0345808B1 (de) 1995-01-11
PT90805B (pt) 1994-10-31
NO892381L (no) 1989-12-11
EP0345808A1 (de) 1989-12-13
HK83295A (en) 1995-06-01
DK283589D0 (da) 1989-06-09
IE66569B1 (en) 1996-01-24
SG32583G (en) 1995-09-01
FI95698C (fi) 1996-03-11
DE68920482T2 (de) 1995-06-01
PT90805A (pt) 1989-12-29
KR0128210B1 (ko) 1998-04-02
NO892381D0 (no) 1989-06-09
JPH0285277A (ja) 1990-03-26
KR910000708A (ko) 1991-01-30
AU624147B2 (en) 1992-06-04
CY1846A (en) 1996-03-08
NO174296B (no) 1994-01-03
CA1337421C (en) 1995-10-24
AU3628289A (en) 1989-12-14
ES2067500T3 (es) 1995-04-01
DK283589A (da) 1989-12-11
FI95698B (fi) 1995-11-30
FI892787A0 (fi) 1989-06-07
NO174296C (no) 1994-04-13

Similar Documents

Publication Publication Date Title
DK283589D0 (da) 1-indolylalkyl-4-(substitueret pyridinyl)-piperaziner
EA200100755A1 (ru) 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты
ES2045109T3 (es) 1-fenil-3-naftaleniloxipropanaminas.
DK249089A (da) Benzamid-forbindelser, der er nyttige som protease-inhibitorer
FI862757A0 (fi) Pyridonkarbonsyraderivat och foerfarande foer framstaellning av dessa.
MX9202844A (es) 1-indolilalquil-4-( alcoxi-pirimidinil) piperazinas y composicion farmaceutica que las contiene.
IL93443A0 (en) Trifluoromethylphenylazolyl-methyloxirane derivatives and fungicides containing these compounds
DE3772015D1 (de) Chinolinverbindung.
GR3003776T3 (de)
ATE86860T1 (de) Praeparat gegen ulcus.
NO875357D0 (no) Kjemiske sammensetninger og deres bruk som brennstoff additiver.
ATE84028T1 (de) Biologisch aktive verbindungen.
ES2003086A6 (es) Procedimiento de obtencion de tienoquinolicinsulfonamidas
DE68905406D1 (de) Chinolin-verbindung.
DE3781986D1 (de) Substituierte chinoxaline.
DE3778088D1 (de) Substituierte pyrimidochinoxaline.
DE69112095D1 (de) 1-Phenoxycarbonyl-2-Pyrrolidon-Derivate und nootrope Wirkstoffe.
IL76936A0 (en) 3-amino-2,3-dihydro-1-benzoxepine compounds,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time